Neurocrine Biosciences, Inc. is a California-based biotechnology company that develops medicines for neurological and endocrine-related disorders. It lobbies Congress and federal agencies mainly about pharmacy issues, including drug pricing and telehealth policies that affect how its products are paid for and delivered. The company has reported hiring BGR Government Affairs and spending about $300,000 across six filings.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BRENT ALAN DEL MONTE
The latest disclosures for this client.
BGR GOVERNMENT AFFAIRS
4ABGR GOVERNMENT AFFAIRS
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
BGR GOVERNMENT AFFAIRS
DANIEL FARMER
BGR GOVERNMENT AFFAIRS
JOEL D. BAILEY
BGR GOVERNMENT AFFAIRS
JOHN STONE
BGR GOVERNMENT AFFAIRS
ms REMY LEIGH BRIM MASON
BGR GOVERNMENT AFFAIRS
RAGHAV AGGARWAL
BGR GOVERNMENT AFFAIRS
ROBB WALTON
BGR GOVERNMENT AFFAIRS
ROBERT WOOD
BGR GOVERNMENT AFFAIRS
BGR GOVERNMENT AFFAIRS
Q4BGR GOVERNMENT AFFAIRS
Q3BGR GOVERNMENT AFFAIRS
Q2BGR GOVERNMENT AFFAIRS
Q1